These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9240717)

  • 1. The impact of core-biopsy on pre-operative diagnosis rate of screen-detected breast cancers.
    Muir BB; Kirkpatrick AE; Anderson TJ; Lamb J; Walsh JS; Chetty U; Dixon JM; Anderson EC; Cunningham M
    Clin Radiol; 1997 Jul; 52(7):566-7. PubMed ID: 9240717
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers.
    Litherland JC; Evans AJ; Wilson AR; Kollias J; Pinder SE; Elston CW; Ellis IO; Yeoman LJ
    Clin Radiol; 1996 Aug; 51(8):562-5. PubMed ID: 8761393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment.
    Ellis IO; Humphreys S; Michell M; Pinder SE; Wells CA; Zakhour HD; ;
    J Clin Pathol; 2004 Sep; 57(9):897-902. PubMed ID: 15333647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses.
    Rakha EA; Lee AH; Reed J; Murphy A; El-Sayed M; Burrell H; Evans AJ; Ellis IO
    Eur J Cancer; 2010 Jul; 46(10):1835-40. PubMed ID: 20392631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Needle core biopsy for screen detected breast lesions: time to raise the bar?
    Verkooijen HM
    Eur J Cancer; 2008 Nov; 44(17):2540-1. PubMed ID: 18930652
    [No Abstract]   [Full Text] [Related]  

  • 6. Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis).
    Rakha EA; El-Sayed ME; Reed J; Lee AHS; Evans AJ; Ellis IO
    Eur J Cancer; 2009 May; 45(7):1162-1167. PubMed ID: 19121932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma.
    Lieske B; Ravichandran D; Wright D
    Br J Cancer; 2006 Jul; 95(1):62-6. PubMed ID: 16755293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on core needle biopsy for radiologically detected breast lesions.
    Nguyen M; McCombs MM; Ghandehari S; Kim A; Wang H; Barsky SH; Love S; Bassett LW
    Cancer; 1996 Dec; 78(11):2340-5. PubMed ID: 8941004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large needle core biopsy--avoidance of biopsy table bombardment by the biopsy needle in stereotactic guided breast biopsy.
    Wong KW; Tsui KW; Lau HY; Yung WT; Yeung MC
    Clin Radiol; 1999 May; 54(5):328-30. PubMed ID: 10362241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic large-gauge core biopsy: its role in the diagnosis of non-palpable mammographic abnormalities presenting to a screening service.
    Sutton S; Dahlstrom JE; Jain S
    Australas Radiol; 1997 May; 41(2):103-8. PubMed ID: 9153803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nova Scotia Breast Screening Program experience: use of needle core biopsy in the diagnosis of screening-detected abnormalities.
    Caines JS; Chantziantoniou K; Wright BA; Konok GP; Iles SE; Bodurtha A; Zayid I; Daniels C
    Radiology; 1996 Jan; 198(1):125-30. PubMed ID: 8539363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate?
    Carder PJ; Liston JC
    J Clin Pathol; 2003 Feb; 56(2):133-8. PubMed ID: 12560393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audit of performance of needle core biopsy diagnoses of screen detected breast lesions.
    El-Sayed ME; Rakha EA; Reed J; Lee AH; Evans AJ; Ellis IO
    Eur J Cancer; 2008 Nov; 44(17):2580-6. PubMed ID: 18632261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of full-field digital mammography on pre-operative diagnosis and surgical treatment of mammographic microcalcification.
    Bundred SM; Zhou J; Whiteside S; Morris J; Wilson M; Hurley E; Bundred N
    Breast Cancer Res Treat; 2014 Jan; 143(2):359-66. PubMed ID: 24318468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stereotaxic breast biopsy techniques have become the standard of care for mammographically suspicious lesions].
    Fehr MK; Hornung R; Von Orelli S; Haller U
    Gynakol Geburtshilfliche Rundsch; 2002; 42(4):201-11. PubMed ID: 12373024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The operative management of screen-detected breast cancers.
    Crawford MD; Biankin AV; Rickard MT; Coleman MJ; West R; Niesche FW; Renwick SR
    Aust N Z J Surg; 2000 Mar; 70(3):168-73. PubMed ID: 10765897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiologic recommendation for breast biopsy on screening mammography reports.
    Geelhoed GW; Barr HM; Curtis DJ; Olmsted WW
    Am Surg; 1991 Jul; 57(7):419-24. PubMed ID: 2058848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of core biopsy for screen-detected breast lesions under 10 mm: implications for surgical management.
    Farshid G; Downey P; Pieterse S; Gill PG
    ANZ J Surg; 2017 Sep; 87(9):725-731. PubMed ID: 25776551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of breast needle core biopsy specimens performed for screen-detected microcalcification.
    Kumaraswamy V; Carder PJ
    J Clin Pathol; 2007 Jun; 60(6):681-4. PubMed ID: 16882700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.